Finance

Beta
Lists
CORONA:NSE
Corona Remedies Ltd
₹2,055.70
+1.63%
(+32.90) 1D
Jul 10, 11:57:09 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
₹2,040.00
High
₹2,070.90
Low
₹2,022.80
Mkt. cap
125.75B
Avg. vol.
53.30K
Volume
7.60K
Dividend
0.49%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
67.92
52-wk high
₹2,100.70
52-wk low
₹1,336.60
EPS
₹30.27
No. of employees
5K
Open
₹2,040.00
High
₹2,070.90
Low
₹2,022.80
Mkt. cap
125.75B
Avg. vol.
53.30K
Volume
7.60K
Dividend
0.49%
Quarterly dividend
₹2.50
Ex-dividend date
Jun 19, 2026
P/E ratio
67.92
52-wk high
₹2,100.70
52-wk low
₹1,336.60
EPS
₹30.27
No. of employees
5K
News stories
From sources across the web
About Corona Remedies Ltd
CEO-
Employees5.15K
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitecoronaremedies.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.47B
3.61B
3.42B
3.53B
Cost of goods sold
673.91M
686.50M
602.70M
772.40M
Cost of revenue
673.91M
686.50M
602.70M
772.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24B
1.03B
959.40M
2.14B
Operating expense
2.18B
2.23B
2.08B
2.24B
Total operating expenses
2.86B
2.92B
2.69B
3.01B
Operating income
610.30M
692.70M
737.10M
522.70M
Other non operating income
2.79M
22.70M
22.40M
-58.90M
EBT including unusual items
606.93M
697.80M
552.10M
547.40M
EBT excluding unusual items
608.38M
697.80M
743.10M
550.20M
Income tax expense
144.97M
174.60M
139.40M
94.10M
Effective tax rate
23.89%
25.02%
25.25%
17.19%
Other operating expenses
855.24M
1.11B
1.03B
-7.00M
Net income
461.96M
523.20M
412.70M
453.30M
Net profit margin
13.33%
14.49%
12.05%
12.84%
Earnings per share
-
-
-
7.41
Interest and investment income
14.57M
-
-
70.60M
Interest expense
-19.37M
-19.30M
-16.60M
-11.10M
Net interest expenses
-4.80M
-19.30M
-16.60M
59.50M
Depreciation and amortization charges
89.18M
92.00M
94.50M
102.90M
EBITDA
690.04M
794.16M
838.56M
608.10M
Gain or loss from assets sale
1.69M
2.61M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer